Search

everythinglearnresearchcommunity

for

Search:↓

Biomaterials with MSC-derived substances could improve tissue repair and have advantages over direct cell therapy.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Melatonin may benefit skin health and could be a promising treatment in dermatology.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Current treatments for alopecia show no significant long-term benefits.

Some skin medications are safe during pregnancy and breastfeeding, but others can harm the baby and should be avoided.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Exosomes could potentially enhance tissue repair and regeneration with lower rejection risk and easier production than live cell therapies.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

Aromatherapy with certain essential oils is a safe and effective treatment for hair growth in alopecia areata patients.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

The document concludes that molluscum contagiosum is a common, benign skin infection in children, often healing without scarring.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

The article concludes that while we understand a lot about how melanocytes age and how this can prevent cancer, there are still unanswered questions about certain pathways and genes involved.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

A certain smell receptor in hair follicles can affect hair growth when activated by a synthetic sandalwood scent.

Fat tissue cells are a promising option for healing various diseases, but more research is needed to ensure they are safe and effective.

Targeting the skin's endocannabinoid system could help treat skin disorders.

Alopecia areata can cause unpredictable hair loss, and treatments like corticosteroids and minoxidil may help but have varying side effects.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Using CRISPR for gene editing in the body is promising but needs better delivery methods to be more efficient and specific.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Squalene-based carriers improve delivery of a treatment to hair follicles for alopecia areata.

Photothermal hydrogels are promising for infection control and tissue repair, and combining them with other treatments could improve results and lower costs.